KCNN4-Mediated Ca²⁺/MET/AKT Axis Is Promising for Targeted Therapy of Pancreatic Ductal Adenocarcinoma

Researchers demonstrated that the level of KCNN4 in pancreatic ductal adenocarcinoma was abnormally elevated, and the overexpression of KCNN4 was induced by transcription factor AP-1.